SCHEMBL7192156

SCHEMBL7192156

COc1ccc(C(C)(C)C)c(OC)c1/C=C/C(=O)c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.51
KRAS P01116 6/20 0.46
TNFRSF1A P19438 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
MAOA P21397 2/20 0.42
ALDH1A1 P00352 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192161 1.00 ABCG2 (0.51) ABCG2KRASTNFRSF1ACYP1A2CYP3A4
SCHEMBL7182394 0.87 CAPN1 (0.55) ABCG2MEN1KMT2AALDH1A1MAOB
SCHEMBL7182392 0.87 CAPN1 (0.55) ABCG2MEN1KMT2AALDH1A1MAOB
SCHEMBL7187114 0.86 ABCG2 (0.39) ABCG2KRASTNFRSF1ACYP1A2CYP3A4
SCHEMBL7187107 0.86 ABCG2 (0.39) ABCG2KRASTNFRSF1ACYP1A2CYP3A4
SCHEMBL7191169 0.86 CA1 (0.58) ABCG2KRASTNFRSF1ACYP1A2CYP3A4
SCHEMBL7191166 0.86 CA1 (0.58) ABCG2KRASTNFRSF1ACYP1A2CYP3A4
SCHEMBL7189079 0.84 ABCG2 (0.55) ABCG2KRASCYP1A2CYP3A4CYP2C9
SCHEMBL7189075 0.84 ABCG2 (0.55) ABCG2KRASCYP1A2CYP3A4CYP2C9
SCHEMBL7184271 0.84 ABCG2 (0.51) ABCG2KRASTNFRSF1ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed